Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Data Science Institute, Hasselt University, Hasselt, Belgium.
J Antimicrob Chemother. 2021 Jul 26;76(12 Suppl 2):ii2-ii6. doi: 10.1093/jac/dkab171.
This article introduces a series of articles on antibiotic consumption in the community between 1997 and 2017, which provide an update of previous articles covering the periods 1997-2003 and 1997-2009.
In this article, differences in participating countries, the ATC/DDD classification system, and data collection, validation and analysis between the current and previous series are described.
In the previous series, 33 European countries provided valid data for further analysis, while the current series focused on 30 countries belonging to the EU or the European Economic Area (EEA). For both series, data were collected in accordance with the WHO ATC classification system. While the previous series reported data in accordance with the ATC/DDD index 2011, the current series employed the ATC/DDD index 2019. Both series focused on consumption of antibacterials for systemic use (ATC J01) and collected data expressed in DDD per 1000 inhabitants per day and packages per 1000 inhabitants per day. When studying consumption expressed in packages per 1000 inhabitants per day, countries reporting total care data, i.e. community and hospital sector combined, were included in the previous series but excluded in the current series. While the previous series used non-linear mixed models to evaluate time trends in antibiotic consumption, the current series allowed for inclusion of change-points with a data-driven location. In addition, both series assessed the composition and quality of antibiotic consumption in the EU/EEA.
The updated analyses of two decades of ESAC-Net data provide the most comprehensive and detailed description of antibiotic consumption in the community in Europe.
本文介绍了 1997 年至 2017 年间社区抗生素使用情况的一系列文章,这些文章更新了之前涵盖 1997-2003 年和 1997-2009 年两个时期的文章。
本文描述了当前系列与之前系列在参与国家、ATC/DDD 分类系统以及数据收集、验证和分析方面的差异。
在前一系列中,有 33 个欧洲国家提供了有效的数据进行进一步分析,而当前系列则侧重于欧盟或欧洲经济区(EEA)的 30 个国家。对于这两个系列,数据都是按照世界卫生组织 ATC 分类系统收集的。在前一系列中,数据是按照 ATC/DDD 索引 2011 报告的,而当前系列则采用了 ATC/DDD 索引 2019。这两个系列都关注全身用抗菌药物(ATC J01)的使用情况,并收集以每 1000 居民每天 DDD 和每 1000 居民每天包装表示的数据。在研究以每 1000 居民每天包装表示的消费情况时,前一系列纳入了报告总护理数据的国家,即社区和医院部门的数据,而当前系列则排除了这些国家。在前一系列中,使用非线性混合模型评估抗生素使用量的时间趋势,而当前系列允许包含数据驱动的位置的变化点。此外,两个系列都评估了欧盟/EEA 中抗生素使用的组成和质量。
对 ESAC-Net 数据二十年的更新分析提供了欧洲社区抗生素使用情况最全面和详细的描述。